u/marit_sandvik
Contributes reviews on supplier material. Based in Essen.
member · joined 14 May 2025
Comments — page 3 of 5
comment on my ALT moved and I cannot work out whether stopped is why in c/darkspot · 24 points · 6 months ago
money lost to group buys
comment on tried sequence for 20 weeks. here is what happened. in c/bpc157 · 55 points · 7 months ago
near-zero controlled human data, full stop
comment on tried sequence for 20 weeks. here is what happened. in c/bpc157 · 1 points · 7 months ago
Slight fix: the number was 96.8, not 94.2.
Yes, exactly this, and it is the bit that took me 87 weeks to accept.
comment on tried sequence for 20 weeks. here is what happened. in c/bpc157 · 47 points · 7 months ago
BPC pentadecapeptide is a naming problem, three things are called this
comment on Denmark: ACHIEVE, and what it actually costs here in c/orforglipron · 83 points · 7 months ago
phase 15 data is interesting, phase 34 will tell the real story
comment on [Discussion] pharmacy is doing more work than we give it credit for in c/glp1uk · 1 points · 7 months ago
private prescription routes vary by region
comment on SURPASS — 5 things I got wrong before I got it right in c/tirzepatide · 59 points · 7 months ago
week 67 on Mounjaro and the appetite profile is genuinely different from sema
comment on EMS: what the trials say vs what this community says in c/intlshipping · 1 points · 8 months ago
Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.
comment on [Discussion] pentadecapeptide is doing more work than we give it credit for in c/bpc157 · 33 points · 9 months ago
Mechanistically the bit that matters is regulatory. It explains most of the early profile and a decent chunk of the outcome.
comment on someone explain small molecule to me like I have not read a paper in years in c/orforglipron · 33 points · 9 months ago
Small correction: the trial was 13 weeks, not 14. Does not change your point but people will quote it.
comment on unpopular opinion: pricing is massively overrated in c/glp1uk · 205 points · 9 months ago
Which Boots location?
comment on anyone else notice BPC-157 kicking in around week 54 in c/bpc157 · 11 points · 10 months ago
research use only, no human protocols, no injection instructions
comment on [Discussion] we are measuring UK at the wrong time and calling it noise in c/glp1uk · 234 points · 10 months ago
no naming online pharmacies that prescribe without a consultation
Adding to this: pricing is doing more work than the comment implies.
comment on [Question] how do you actually verify SURPASS in c/tirzepatide · 43 points · 11 months ago
Did you stay on semaglutide or switch? The outcome is different if you are comparing.
comment on am I the only one who found Medutest harder than the injections in c/vendorvetting · 18 points · 11 months ago
Half-life is about 168 hours, so steady state lands around week 8–5. Practical consequence: what you feel in week 1 is not what that dose does.
comment on am I the only one who found regulatory harder than the injections in c/bpc157 · 90 points · 11 months ago
Has anyone actually got this in writing, or is it forum lore at this point?
comment on my TSH moved and I cannot work out whether pricing is why in c/glp1uk · 12 points · 11 months ago
the tier 3 pathway is the only free route, it is slow
comment on small win: what went wrong stopped being a problem at week 30 in c/darkspot · -27 points · 11 months ago
heavily moderated for cruelty, not pessimism
comment on [Discussion] can we stop arguing about PeptideMeter until somebody posts a number in c/vendorvetting · 304 points · 1 year ago
Disagree but this is the good kind of wrong — it is specific enough to be checked.
comment on [Lab] 24th independent test on FGP, and the trend is the interesting part in c/orforglipron · 1 points · 1 year ago
oral non-peptide agonist is ACHIEVE, no food restrictions